Sheldon RS - Search Results

1

Right and left ventricular function during chronic amiodarone therapy.

Sheldon RS, Mitchell LB, Duff HJ, Wyse DG, Manyari DE. Sheldon RS, et al. Am J Cardiol. 1988 Oct 1;62(10 Pt 1):736-40. doi: 10.1016/0002-9149(88)91213-1. Am J Cardiol. 1988. PMID: 3421174

2

Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.

Chiamvimonvat N, Mitchell LB, Gillis AM, Wyse DG, Sheldon RS, Duff HJ. Chiamvimonvat N, et al. Among authors: sheldon rs. Am J Cardiol. 1992 Sep 1;70(6):598-604. doi: 10.1016/0002-9149(92)90198-8. Am J Cardiol. 1992. PMID: 1324598

3

Cyclic AMP-dependent regulation of the number of [3H]batrachotoxinin benzoate binding sites on rat cardiac myocytes.

Taouis M, Sheldon RS, Hill RJ, Duff HJ. Taouis M, et al. Among authors: sheldon rs. J Biol Chem. 1991 Jun 5;266(16):10300-4. J Biol Chem. 1991. PMID: 1645346 Free article.

4

Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug.

Taouis M, Sheldon RS, Duff HJ. Taouis M, et al. Among authors: sheldon rs. J Clin Invest. 1991 Aug;88(2):375-8. doi: 10.1172/JCI115313. J Clin Invest. 1991. PMID: 1650791 Free PMC article.

5

Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.

Sheldon RS, Duff HJ, Hill RJ. Sheldon RS, et al. Clin Invest Med. 1991 Oct;14(5):458-65. Clin Invest Med. 1991. PMID: 1660368 Review.

6

Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.

Duff HJ, Mitchell LB, Wyse DG, Gillis AM, Sheldon RS. Duff HJ, et al. Among authors: sheldon rs. Clin Invest Med. 1991 Oct;14(5):476-83. Clin Invest Med. 1991. PMID: 1660369 Review.

7

Transcainide: biochemical evidence for state-dependent interaction with the class I antiarrhythmic drug receptor.

Hill RJ, Thakore E, Taouis M, Duff HJ, Sheldon RS. Hill RJ, et al. Among authors: sheldon rs. Eur J Pharmacol. 1991 Oct 2;203(1):51-8. doi: 10.1016/0014-2999(91)90789-s. Eur J Pharmacol. 1991. PMID: 1665791

8

Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.

Duff HJ, Rahmberg M, Sheldon RS. Duff HJ, et al. Among authors: sheldon rs. J Cardiovasc Pharmacol. 1990 Nov;16(5):685-92. doi: 10.1097/00005344-199011000-00001. J Cardiovasc Pharmacol. 1990. PMID: 1703588

9

Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.

Sheldon RS, Rahmberg M, Duff HJ. Sheldon RS, et al. J Cardiovasc Pharmacol. 1990 Nov;16(5):818-23. doi: 10.1097/00005344-199011000-00019. J Cardiovasc Pharmacol. 1990. PMID: 1703606

10

Drug therapy for ventricular tachyarrhythmias: how many electropharmacologic trials are appropriate?

Kavanagh KM, Wyse DG, Duff HJ, Gillis AM, Sheldon RS, Mitchell LB. Kavanagh KM, et al. Among authors: sheldon rs. J Am Coll Cardiol. 1991 Feb;17(2):391-6. doi: 10.1016/s0735-1097(10)80104-4. J Am Coll Cardiol. 1991. PMID: 1991895 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters